Urea cycle enzymes (UCE)

The urea cycle enzymes represent a critical metabolic pathway consisting of six primary enzymes: N-acetylglutamate synthase (NAGS), carbamoyl phosphate synthetase 1 (CPS1), ornithine transcarbamylase (OTC), argininosuccinate synthetase 1 (ASS1), argininosuccinate lyase (ASL), and arginase 1 (ARG1). These enzymes work in concert within the mitochondria and cytosol of hepatocytes to convert toxic ammonia, a byproduct of protein metabolism, into water-soluble urea for renal excretion (StatPearls, NBK482121). Deficiencies in any of these enzymes result in urea cycle disorders (UCDs), which are characterized by life-threatening hyperammonemia, cerebral edema, and progressive neurological impairment (NIH GARD, 7837). Pharmacological targeting of this pathway involves nitrogen-scavenging agents like sodium phenylbutyrate and glycerol phenylbutyrate, which provide alternative routes for nitrogen disposal by conjugating with glutamine and glycine (PubChem, CID 5282492). Additionally, specific enzyme deficiencies are addressed through cofactor supplementation (e.g., carglumic acid for NAGS) or recombinant enzyme replacement (e.g., pegzilarginase for ARG1). Recent clinical advancements have focused on gene therapy and mRNA-based approaches to restore endogenous enzyme expression, offering the potential for long-term metabolic stability in affected patients.

Other names

Ornithine cycle enzymesKrebs-Henseleit cycle enzymesNitrogen detoxification enzymes

Nitrogen scavenging via alternative pathway activation, allosteric activation of carbamoyl phosphate synthetase 1, recombinant enzyme replacement, substrate supplementation, and gene replacement therapy.